Allysta Pharmaceuticals – Innovation Showcase at Ophthalmology Innovation Summit @ AAO 2019

Henry Hsu, MD, and CEO of Allysta Pharma, talks about the unmet needs of dry eye and ALY688’s promise for treating symptoms of the disease as it heads into a phase 1/2a study.

Henry Hsu, MD speaks for Allysta Pharmaceuticals during the Innovative Showcase at OIS@AAO 2019.

REGISTER for our next ophthalmology conference today.